Biolife Solutions (BLFS) Non-Current Deffered Revenue (2010 - 2021)
Biolife Solutions (BLFS) reported Non-Current Deffered Revenue of $64000.0 for Q1 2021, down 9.86% on a QoQ basis from $71000.0 in Q4 2020.
Biolife Solutions (BLFS) has 11 years of Non-Current Deffered Revenue data on file, last reported at $64000.0 in Q1 2021.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $64000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $64000.0 (changed N/A YoY) and the FY2020 annual result came in at $71000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue slipped to $64000.0 in Q1 2021 per BLFS's latest filing, from $71000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $656581.0 in Q3 2017 and bottomed at -$62984.0 in Q1 2017.
- The 4-year median for Non-Current Deffered Revenue is $349000.0 (2018), against an average of $257346.6.
- Peak annual rise in Non-Current Deffered Revenue reached 2575.45% in 2017, while the deepest fall reached 572.32% in 2017.
- Tracing BLFS's Non-Current Deffered Revenue over 4 years: stood at $492000.0 in 2017, then slipped by 29.07% to $349000.0 in 2018, then tumbled by 79.66% to $71000.0 in 2020, then declined by 9.86% to $64000.0 in 2021.
- Per Business Quant, the three latest BLFS Non-Current Deffered Revenue figures stand at $64000.0 (Q1 2021), $71000.0 (Q4 2020), and $349000.0 (Q4 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 163.15 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 11.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 206.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Dec 31, 2018 | 349,000.00 |
| Sep 30, 2018 | 386,113.00 |
| Jun 30, 2018 | 422,828.00 |
| Dec 31, 2017 | 492,000.00 |
| Sep 30, 2017 | 656,581.00 |
| Jun 30, 2017 | -62,419.00 |
| Mar 31, 2017 | -62,984.00 |
| Dec 31, 2016 | 27,989.00 |
| Sep 30, 2016 | 24,541.00 |
| Jun 30, 2016 | 19,929.00 |
| Mar 31, 2016 | 13,335.00 |
| Dec 31, 2015 | 36,632.00 |
| Sep 30, 2015 | 29,700.00 |
| Jun 30, 2015 | 21,651.00 |
| Mar 31, 2015 | 4,966.00 |
| Dec 31, 2014 | 39,509.00 |
| Sep 30, 2014 | -18,007.00 |
| Mar 31, 2014 | -5,227.00 |
| Dec 31, 2013 | 995.00 |
| Sep 30, 2013 | -8,780.00 |
| Jun 30, 2013 | 942,955.00 |
| Mar 31, 2013 | -27,412.00 |
| Dec 31, 2012 | 89,167.00 |
| Sep 30, 2012 | 46,189.00 |
| Mar 31, 2012 | -6,134.00 |
| Dec 31, 2011 | 109,167.00 |
| Jun 30, 2011 | 119,167.00 |
| Dec 31, 2010 | 129,167.00 |